recent ion-beam therapy proposals in chinaerice2009.na.infn.it/talkcontributions/wei.pdftalk by a...

21
1 Hadron Therapy in China, Wei et al Recent ion-beam therapy proposals in China talk by a simple-minded accelerator physicist Jie Wei, Tsinghua University, China S.N. Fu, Y. Jiao, S. Wang, IHEP, CAS, China R. Ma, MSKCC, USA S. Peggs, T. Satogata, BNL, USA Workshop on Hadron Beam Therapy of Cancer Erice, Italy, April 24 – May 1, 2009 2 Hadron Therapy in China, Wei et al Outline existing facilities current activities debates in possible approaches EMIT attempt: (energy modulation ion therapy) R&D experiences in hadron accelerators hadron accelerator demands & CPHS: (compact pulsed hadron source) dream of a hadron accelerator physicist

Upload: others

Post on 31-Jan-2021

1 views

Category:

Documents


0 download

TRANSCRIPT

  • 1Hadron Therapy in China, Wei et al

    Recent ion-beam therapy proposals in China

    talk by a simple-minded accelerator physicist

    Jie Wei, Tsinghua University, ChinaS.N. Fu, Y. Jiao, S. Wang, IHEP, CAS, China

    R. Ma, MSKCC, USAS. Peggs, T. Satogata, BNL, USA

    Workshop on Hadron Beam Therapy of CancerErice, Italy, April 24 – May 1, 2009

    2Hadron Therapy in China, Wei et al

    Outline

    � existing facilities� current activities� debates in possible approaches� EMIT attempt:

    (energy modulation ion therapy)

    � R&D experiences in hadron accelerators� hadron accelerator demands & CPHS:

    (compact pulsed hadron source)� dream of a hadron accelerator physicist

  • 3Hadron Therapy in China, Wei et al

    4Hadron Therapy in China, Wei et al

    Rationale for the ion-beam facility needs

    � Population of 1.32 billions;

    20% of world population� 1 proton facility per 10M population:

    132 proton machines� 1 carbon facility per 50M population:

    26 carbon machines� 1 – 2 machines per province:

    30 – 60 ion-beam machines

  • 5Hadron Therapy in China, Wei et al

    IMP facility Wanjie hospital/IBA

    Existing ion beam therapy facilities in China

    6Hadron Therapy in China, Wei et al

    Wanjie proton therapy hospital

    � Proton facility based on IBA cyclotron/gantry

    � Treatment of more than 300 patientsCourtesy Wanjie

  • 7Hadron Therapy in China, Wei et al

    Lanzhou heavy ion therapy research center

    � Institute of Modern Physics, Chinese Academy of Sciences (parasitic)

    � Recent treatment with the heavy ion synchrotron

    � Previous treatment (near 100) with the heavy ion cyclotron

    Courtesy IMP, CAS

    8Hadron Therapy in China, Wei et al

    SFC

    TR5

    TR3TR4

    TR2

    TR1

    TL2

    TL1

    SSC PDC

    T1

    RIBLL1

    RIBLL2

    PT

    12.1 Tm

    1.1GeV/u—C6+

    2.8Gev--p

    9.4 Tm

    500MeV/u—U92+

    K=450

    K=69HIRFLHIRFL

    (161m)

    (128.8m)

    Lanzhou HIRFL-CSR Layout

  • 9Hadron Therapy in China, Wei et al

    Proposed ion beam therapy facilities in China

    10Hadron Therapy in China, Wei et al

    Shanghai Proton Heavy-ion Hospital proposal

    � $330M investment by Shanghai municipal government – contract with

    Siemens for $190M for construction

    – 55 months– carbon-proton in

    one synchrotron– no gantry

    Courtesy SHCCAC

  • 11Hadron Therapy in China, Wei et al

    Debates in possible approaches

    � Goal: ion-beam therapy with capability of 3D stereo-tactic scanning

    � At least 5 ways to build the machine– Cyclotron with mechanical degrader: PSI

    practice– Slow-cycling synchrotron with energy-

    programming slow extraction: GSI practice– Rapid cycling synchrotron: resonance

    acceleration with adjustable extraction timing– FFAG-ring based– Linac based

    12Hadron Therapy in China, Wei et al

    Rationale to choose the RCS approach

    � well established technology– proven example of ISIS (50Hz), J-PARC (25Hz)

    � new to the therapy world– smaller beam size, lighter gantry … (e.g. Peggs)

    � share the R&D efforts in China– China Spallation Neutron Source (CSNS)

    � Primary challenge:– Lower cost (30 – 50%), quality production– World-wide collaboration, domestic fabrication

    � Possible weakness:– Large amount of RF (C: < 100 kV for 50 Hz)

  • 13Hadron Therapy in China, Wei et al

    EMIT attempt: Guangdong/IHEP

    � EMIT workshop, April 2008

    14Hadron Therapy in China, Wei et al

    EMIT-p layout

  • 15Hadron Therapy in China, Wei et al

    EMIT-p EMIT-CClinical specification 3 treatment rooms fixed ports Room 1 horizontal port; scattering mode Room 2 diagonal port; scanning mode

    optional horizontal, vertical ports Room 3 +/- 190 deg. gantry; scanningIon species p (proton) C (carbon)Beam kinetic energy 60-250 MeV 20-450 MeV/uAverage dose rate 20 Gy/min.(scan); 2 Gy/min. (scatt.)Field size 20 cm x 20 cmDose uniformity ± 4% of the prescribed doseDose delivered accuracy ± 2%Irradiation method scattering; spot scanning; spot scanning;

    respiration synchronization respiration synchronizat ionCycle repetition rate 25 - 50 Hz 25 HzBeam position accuracy at iso-center ± 0.5 mmAccuracy of patient positioning 0.5 mmLevel and time for energy change 250 levels; < 2 sLevel and time for position change 250 levels; < 20 msBeam intensity per cycle, max 2.0x109 3x107

    Beam intensity per cycle, min 2.0x107

    Range and time for intensity change factor of 7; < 20 msBeam spot size at isocenter 1-10 mm (FWHM)Beam relative momentum spread 0.1% (FWHM)Time for cut beam off < 20 msMain accelerator type rapid cycling synchrotron rapid cycling synchrotronAccelerator injector type proton source, RFQ, DTL

    EMIT: rapid cycling synchrotron based

    16Hadron Therapy in China, Wei et al

    Energy Modulation Ion Therapy (EMIT) layout

  • 17Hadron Therapy in China, Wei et al

    EMIT-p injector

    �The linac consists of a 50 kV ion source, a 2.5 MeV RFQ, a 10 MeV DTL with a total length of 6.5 m

    %0.2Energy spread

    um0.15Emittance(norm. rms)

    ns50-350Pulse length

    Hz25 - 50Pulse repetition rate

    mA1Pulse current

    MeV10Output energy

    18Hadron Therapy in China, Wei et al

    EMIT-p RCS lattice A

  • 19Hadron Therapy in China, Wei et al

    EMIT-p RCS lattice B

    20Hadron Therapy in China, Wei et al

    CSNS vs. EMIT-p comparison

    81Number of power supply

    1.56××××10132.0××××109Proton number per pulse

    16.40.4Power consumption ((((MW)

    81Number of RF cavity3000Total weight of quads (ton)480Number of quads6008Total weight of dipoles (ton)2424Number of dipoles

    1600250 – 270Ext. energy of RCS (MeV)240~ 30Circumference of RCS (m)13010Linac energy (MeV)706.5Linac length (m)

    CSNSEMIT-pParameters

  • 21Hadron Therapy in China, Wei et al

    建设场地广东东莞大朗建设场地广东东莞大朗建设场地广东东莞大朗建设场地广东东莞大朗 ⋅⋅⋅⋅ 松山湖松山湖松山湖松山湖

    China Spallation Neutron Source layout

    22Hadron Therapy in China, Wei et al

    CSNS component prototyping

    RCS 1.6 GeV25 Hz, 63 µA

    H- IS, 50 keVIp = 20 mA

    RFQ, 3 MeV324 MHz

    DTL, 80 MeVIave=75 µA

    Room for higher energy linac

    Collimation & cleaning

    Target station & neutron instruments

    Future medicalapplications

    Future proton applications

    To future second target, muon target, fast neutron

    Linac RF

    Bending dipole

    Injectionbump

    Power supply

    Vacuum chamber

    Ring RF

    Extraction

  • 23Hadron Therapy in China, Wei et al

    Major existing/proposed accelerator facilities in China

    BEPC

    CPHS

    NSRL

    SSRF

    NSRRC

    CSR

    CSNS

    24Hadron Therapy in China, Wei et al

    Major demands for hadron accelerator

    � Thorium fueled accelerator driven subcriticalreactor (ADS) for power generation

    � ADS for nuclear waste transmutation

    � multi-disciplinary platform neutron source� ion beam therapy� compact neutron and proton sources

  • 25Hadron Therapy in China, Wei et al

    ADS for waste transmutation

    – By 2020, addition of nuclear power of 40 GWe, by 2050 reaching 240 GWe. 25 tons of waste per 1 GWe reactor plant.

    – Transmutation of MA and LLFP material.

    26Hadron Therapy in China, Wei et al

    Neutron scattering applications

    能量输送能量输送能量输送能量输送

    药物设计药物设计药物设计药物设计新材料制造处理过程新材料制造处理过程新材料制造处理过程新材料制造处理过程

    药物学药物学药物学药物学环境科学环境科学环境科学环境科学

    纳米生物科技纳米生物科技纳米生物科技纳米生物科技 洁净化科技洁净化科技洁净化科技洁净化科技

    催花剂催花剂催花剂催花剂

    能量储藏能量储藏能量储藏能量储藏

    文化遗产文化遗产文化遗产文化遗产

    先进材料先进材料先进材料先进材料

    量子仪器量子仪器量子仪器量子仪器

    交通交通交通交通

    数据储存及处理数据储存及处理数据储存及处理数据储存及处理

    物理物理物理物理 1960 化学化学化学化学 1970 生物生物生物生物 1980 能源能源能源能源…1990

    21世纪世纪世纪世纪

  • 27Hadron Therapy in China, Wei et al

    IS RF

    QDTL

    target station

    proton stations

    synchrotron

    Hadron

    therapy

    ADS

    rotation

    gantry

    fixed gantry

    calibration

    gantry

    1

    2

    34

    5

    6

    1: neutron R&D beamline

    2: engineering diffraction

    3: irradiation station

    4: neutron radiography/ imaging

    5: small angle neutron scattering

    6: neutron therapy

    B

    A

    C

    D

    G

    Neutron

    applications

    Proton

    accelerator

    Proton

    applications

    neutron instruments

    A possible hadron facility layout

    28Hadron Therapy in China, Wei et al

    F High-PowerSNS(3-8MW)

    22MeV 2GeVRFQ DTL Low Beta SC

    SC Linac

    H+

    H-

    Ion Source

    H-

    H+

    Accumulator

    H-

    G transmutation

    C+

    RFQ IH

    E C iontherapy

  • 29Hadron Therapy in China, Wei et al

    Compact Pulsed Hadron Source

    30Hadron Therapy in China, Wei et al

    CPHS in phases

    Medical

    Powder diffraction

    DevicesReflectometer

    Activation

    SANS

    Imagining

    SANS: Large (~1-100nm) structure of assemblies in solid, liquid, powder forms� Micro-to-nano structures of

    composites� Biology, nanobiotechnology� Polymers and soft matters� Complex systems

    Reflectometry: Films & (internal) surfaces including liquid interfaces� Sensor & device heterostructures� Biology, nanobiotechnology� Polymers and soft matters� Complex systems

    Devices: Frontiers of neutron optics� Beam filters� Detector development� Neutron polarization

    Medical: Neutron therapy� BNCT� Nuclear medicine

    Powder diffraction: Crystal structure� Solid-state chemistry & physics� Novel materials

    Activation : Chemical analysis of materials

    � Elementary analysis� Nuclear materials, security

    Phase I

    Phase II

  • 31Hadron Therapy in China, Wei et al

    32Hadron Therapy in China, Wei et al

    CPHS major parameters

    �ion source, RFQ, DTL, RF

    �Be target

    �neutron scattering�neutron imaging�proton application

    �Phase I program in 3 years�Existing building on main campus�Starting funds available

  • 33Hadron Therapy in China, Wei et al

    CPHS accelerator parameters

    34Hadron Therapy in China, Wei et al

    Electron facilities from LARGE …

    � Shanghai synchrotron light source, 2008Courtesy SSRF

  • 35Hadron Therapy in China, Wei et al

    To small …

    36Hadron Therapy in China, Wei et al

    … small yet useful

  • 37Hadron Therapy in China, Wei et al

    Hadron facilities from LARGE …

    � Spallation Neutron Source, 2005Courtesy SNS, ORNL

    38Hadron Therapy in China, Wei et al

    Laser-generated nanosecond pulsed neutron sources: scaling from VULCAN to table-top, Zager et al, New J. Phys.(2005)

    � Compact, table-top sources yet producing useful neutron fluxes for practical applications

    � Broad fast neutron spectrum� Forward directed beams� Pulsed operation, short pulse and high

    repetition rates

    Neutron Interrogation Devices

    Using neutron/proton-induced reactions for non-destructive bulk elemental analysis.

    Detecting buried objects, mine clearing, geophysical applications,…

    To small yet innovative …

    Courtesy C. K. Loong

  • 39Hadron Therapy in China, Wei et al

    DREAM of a hadron accelerator physicist

    � from small to LARGE– Lawrence’s 12-cm dia. Cyclotron to SNS

    � from LARGE to small– From SNS and ADS to compact ion-beam

    therapy & neutron sources

    � building affordable machines– able to build facilities at a budget much

    lower than the “world standard” cost

    � making hadron accelerators indispensable parts of mankind’s life

    40Hadron Therapy in China, Wei et al

    THANK YOU!

  • 41Hadron Therapy in China, Wei et al

    Acknowledgements

    � To the EMIT team– C. D. Deng, S. X. Fang, S. N. Fu, H. Sun, D.

    K. Liu, L. Liu, H. M. Qu, H. Shu, J. Y. Tang, S. Wang, J. Yi, J. Zhang …

    � To the CSNS team– IHEP and IPHY, CAS

    � To the CPHS team– C. K. Loong, Tsinghua Univ.

    � To friends, colleagues, and collaborators in China and worldwide